Use of Janus kinase inhibitors in atopic dermatitis – an update

Safety of upadacitinib in moderate-to-severe atopic dermatitis: An integrated analysis of phase 3 studies

(2022) Emma Guttman-Yassky et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Ruxolitinib Cream Ameliorates Itch and Inflammation in Preclinical Models of Dermatitis

(2021) Monika Scuron et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Efficacy and Safety of Ruxolitinib Cream for the Treatment of Atopic Dermatitis: Results From Two Phase 3, Randomized, Double-Blind Studies

(2021) Kim Papp et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Systematic Review on the Efficacy and Safety of Oral Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis

(2021) Michelle Le et al.   Frontiers in Medicine

Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials

(2020) E.L. Simpson et al.   BRITISH JOURNAL OF DERMATOLOGY

Delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with moderate to severe atopic dermatitis: A phase 3, randomized, double-blind, vehicle-controlled study and an open-label, long-term extension study

(2020) Hidemi Nakagawa et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Effects of Ruxolitinib Cream on Pruritus and Quality of Life in Atopic Dermatitis: Results From a Phase 2, Randomized, Dose-Ranging, Vehicle- and Active-Controlled Study

(2020) Brian S. Kim et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

(2020) Eric L Simpson et al.   LANCET

Genetic and Epigenetic Aspects of Atopic Dermatitis

(2020) Bogusław Nedoszytko et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Oral JAK/SYK-inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in atopic dermatitis

(2019) Ana B. Pavel et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Treatment of atopic dermatitis with ruxolitinib cream (JAK1/JAK2 inhibitor) or triamcinolone cream

(2019) Brian S. Kim et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Upadacitinib in Adults With Moderate-to-Severe Atopic Dermatitis: 16-Week Results From a Randomized, Placebo-Controlled Trial

(2019) Emma Guttman-Yassky et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Immunologic, microbial, and epithelial interactions in atopic dermatitis

(2018) Patrick M. Brunner et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Efficacy and safety of topical JTE-052, a Janus kinase inhibitor, in Japanese adult patients with moderate-to-severe atopic dermatitis: a phase II, multicentre, randomized, vehicle-controlled clinical study

(2018) H. Nakagawa et al.   BRITISH JOURNAL OF DERMATOLOGY

Baricitinib in adult patients with moderate-to-severe atopic dermatitis: a phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study

(2018) Emma Guttman-Yassky et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Lymphoma in the Tofacitinib Rheumatoid Arthritis Clinical Development Program

(2018) Xavier Mariette et al.   ARTHRITIS CARE & RESEARCH

Atopic Dermatitis: Global Epidemiology and Risk Factors

(2015) Sophie Nutten   ANNALS OF NUTRITION AND METABOLISM

Abstract 792: ASN002: A novel dual SYK/JAK inhibitor with strong antitumor activity

(2015) Sanjeeva Reddy et al.   CANCER RESEARCH

The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization

(2015) Shinji Noda et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

The Ashwell-Morell receptor regulates hepatic thrombopoietin production via JAK2-STAT3 signaling

(2014) Renata Grozovsky et al.   NATURE MEDICINE

Inhibition of JAK kinases in patients with rheumatoid arthritis: scientific rationale and clinical outcomes

(2010) Richard J. Riese et al.   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY